3D Bioprinting of Giant Salamander Mucin‐Based Bioink for Enhanced Bone Regeneration
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.202504181 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Yucan Jiang und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Affiliated Stomatological Hospital of Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Bone Regeneration, Printing, Three-Dimensional, Bioprinting, Ink. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Chongqing Municipal Special Program for Technological Innovation and Application Development, CQMU Program for Youth Innovation in Future Medicine.
Abstract (Originalsprache)
There is an urgent need to overcome the limitations associated with limited autologous bone availability, allogeneic bone rejection, and the insufficient bioactivity of traditional materials for bone‐defect repair. In this study, skin secretions from Andrias davidianus (SSAD) were compounded with methacrylated gelatin (GelMA) to develop a novel bioink and construct bone‐regeneration scaffolds loaded with osteoblasts via extrusion‐based 3D bioprinting. The optimized GelMA/SSAD bioink (50% v/v SSAD, 6% w/v GelMA) demonstrated excellent printability characterized by shear‐thinning behavior and high‐resolution structure formation and significantly enhanced mechanical strength. In vitro studies demonstrated that the scaffolds were not only biocompatible but also effective in promoting osteoblast proliferation, differentiation, and mineralization, as evidenced by significantly increased ALP activity and the upregulated expression of key osteogenic genes (RUNX2 and OCN). In a rat cranial bone defect model, the new bone volume fraction of the GelMA/SSAD scaffolds (12.54%) was markedly higher than that of the pure GelMA control group (9.82%) eight weeks after implantation. Multimodal analyses revealed that the scaffold synergistically accelerated bone regeneration by promoting TRAP‐positive osteoclast activity and increasing type III collagen deposition. Overall, this SSAD‐based bioink combines excellent printability, biocompatibility, and strong osteogenic activity, thereby providing a promising strategy for functional bone repair.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Affiliated Stomatological Hospital of Chongqing Medical University, Chongqing, China.
- Chongqing Key Laboratory of Oral Diseases, Chongqing, China.
- Chongqing Municipal Key Laboratory of Oral Biomedical Engineering Of Higher Education, Chongqing, China.
- Chongqing Municipal Health Commission Key Laboratory of Oral Biomedical Engineering, Chongqing, China.
- The Maternal and Child Health Care Hospital of Xiangtan City, Hunan, China.
- Shizhu County People's Hospital, Chongqing, China.
ORCID-Profile: Yucan Jiang, Ximu Zhang
Förderung
- National Natural Science Foundation of China
- Chongqing Municipal Special Program for Technological Innovation and Application Development
- CQMU Program for Youth Innovation in Future Medicine
- Chongqing Municipal Education Commission
- Science Fund for Distinguished Young Scholars of Chongqing Municipality
Zitieren
APA
Jiang, Y., Zhu, D., Dang, R., Li, L., Xiang, Y., Zhang, Q., Ma, Y., & Zhang, X. (2026). 3D Bioprinting of Giant Salamander Mucin‐Based Bioink for Enhanced Bone Regeneration. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202504181
Vancouver
Jiang Y, Zhu D, Dang R, Li L, Xiang Y, Zhang Q, et al. 3D Bioprinting of Giant Salamander Mucin‐Based Bioink for Enhanced Bone Regeneration. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202504181
BibTeX
@article{Jiang2026,
author = {Jiang, Yucan and Zhu, Dan and Dang, Ruyi and Li, Lan and Xiang, Yangfan and Zhang, Qianyu and Ma, Yufei and Zhang, Ximu},
title = {3D Bioprinting of Giant Salamander Mucin‐Based Bioink for Enhanced Bone Regeneration},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.202504181}
}
EUVIMED